Kos Biotechnology Partners confirms third close of fund at $123m

Kos Biotechnology Partners, a global life sciences investment company, has made its third closing of its first life sciences fund at $123m. The fund – which initially launched in December 2025 – secured investment from a wide range of prominent institutional investors and global family offices. According to Kos, Kos Biotechnology Partners is the first …